Investor Relations
Investor Relations Contact:
LHA
Anne Marie Fields
212-838-3777
afields@lhai.com
or
Bruce Voss
310-691-7100
bvoss@lhai.com

Media Contact
Rooney & Associates
Terry Rooney
212-223-0689
trooney@rooneyco.com
or
Marion Janic
212-223-4017
mjanic@rooneyco.com

OPKO Health Reports 2017 Third Quarter Highlights and Financial Results more »

OPKO Health Submits Premarket Approval Application with FDA for a Point-of-Care PSA Test with the Claros® 1 Platform more »

OPKO Health to Announce 2017 Third Quarter Financial Results on November 8, 2017 more »

OPKO Health Licensee TESARO Announces FDA Approval of VARUBI® IV for Delayed Nausea and Vomiting Associated with Chemotherapy more »

Investor FAQs

OPKO Health was incorporated in Delaware in 1991 as Cytoclonal Pharmaceutics, Inc.

 

The company expects to report the financial results for the fourth quarter 2016 on March 1, 2017. 

OPKO Health common stock is traded on the New York Stock Exchange under the symbol “OPK.”

The company’s most recent investor presentation is available in the “Investors” section on the company’s website. It can also be accessed at the “Events” page of the “Investors” section on the company’s website.

The fiscal year ends on December 31.

No.

OPKO Health does not offer a direct stock purchase plan. Shares of the company can be purchased through a brokerage company.

OPKO Health, Inc. has never declared or paid cash dividends. The company intends to retain any future earnings for the operation and expansion of its business and does not anticipate paying any cash dividends in the foreseeable future.

The date and location will be published in the company’s proxy statement, which can be found on the “SEC Filings” section in the “Investors” section on the company’s website.

OPKO Health Corporate Headquarters
4400 Biscayne Blvd.

Miami, FL 33137

Tel: (305) 575-4100

American Stock Transfer & Trust Company, LLC,

6201 15th Ave.

Brooklyn, NY 11209
Toll-free at (877) 248-6417 or

(718) 921-8317

https://www.amstock.com/main/nav_contactUs.asp

To replace lost stock certificates, please contact OPKO Health’s transfer agent

To change your address, please contact OPKO Health’s transfer agent.

For questions related to the exchange of BRLI shares for OPK shares, please contact OPKO Health’s transfer agent.

 

Please submit your question using the form below.

Please submit your question using the form below. * Required fields

 
 
 
 
 
 
This helps OPKO Health, Inc. prevent automated submissions.
 

Email  Sign up for email alerts